Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 05, 2020

SELL
$3.5 - $7.31 $35,889 - $74,956
-10,254 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$4.6 - $7.88 $21,252 - $36,405
-4,620 Reduced 31.06%
10,254 $80,000
Q2 2019

Aug 06, 2019

BUY
$4.2 - $8.7 $16,270 - $33,703
3,874 Added 35.22%
14,874 $129,000
Q1 2019

May 14, 2019

BUY
$4.75 - $7.1 $52,250 - $78,100
11,000 New
11,000 $55,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $839M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Stone Ridge Asset Management LLC Portfolio

Follow Stone Ridge Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone Ridge Asset Management LLC with notifications on news.